Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 1/2 1

Status

Completed 30Recruiting 18Unknown 6Terminated 5Active not recruiting 4Withdrawn 2Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 12INDUSTRY 5NETWORK 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 4Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 2Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Gallbladder Neoplasms 1Disease Progression 1Cholangiocarcinoma 1Bile Duct Neoplasms 1

Interventions

pembrolizumab 183Carboplatin 130Paclitaxel 123Gemcitabine 122Docetaxel 96Cyclophosphamide 89Nivolumab 88Cisplatin 87Rituximab 71Dexamethasone 68Pemetrexed 64Bevacizumab 64Capecitabine 60atezolizumab 53fludarabine 49Azacitidine 49Fluorouracil 48130-nm albumin-bound paclitaxel 43venetoclax 41Trastuzumab 41Irinotecan 41Cetuximab 39Leucovorin 36Ipilimumab 36Erlotinib Hydrochloride 34Fulvestrant 32Cytarabine 32avelumab 31Oxaliplatin 31Albumin-Bound Paclitaxel 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × Folfox protocol × Clear all
NCT05712356 2026-05-26

BOLSTER

Lisata Therapeutics, Inc.

Phase 2 Terminated
66 enrolled 12 charts
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Disease Progression

NCT05039944 2024-07-18

SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 2 Terminated
7 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04729205 2023-09-14

Assessment of Safety and Therapeutic Efficacy of Promitil in Combination With Folfox in Patients With GI Malignancies

Lipomedix Pharmaceuticals Inc.

Phase 1 Terminated
9 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT03035253 2020-08-11

A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer

Mereo BioPharma

Phase 1 Terminated
16 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01632306 2019-01-15

A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer

Eli Lilly and Company

Phase 1/2 Terminated
13 enrolled 12 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡